APA

De Backer M., De Vroey C., Lesaffre E., Scheys I. & De Keyser P. (19980528). Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. : Journal of the American Academy of Dermatology.

Chicago

De Backer M, De Vroey C, Lesaffre E, Scheys I and De Keyser P. 19980528. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. : Journal of the American Academy of Dermatology.

Harvard

De Backer M., De Vroey C., Lesaffre E., Scheys I. and De Keyser P. (19980528). Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. : Journal of the American Academy of Dermatology.

MLA

De Backer M, De Vroey C, Lesaffre E, Scheys I and De Keyser P. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. : Journal of the American Academy of Dermatology. 19980528.